BRUSSELS (dpa-AFX) - Takeda Pharmaceutical Co. Ltd. (TAK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has recommended the approval
If Approved, Maribavir Would be the First and Only Inhibitor of CMV-specific UL97 Protein Kinase in the EU for Treatment of Adults with Post-transplant CMV Refractory (With or Without Resistance) to
Nel ASA: Das war noch nichts, aber… wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.